Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese

Ocular Immunology and Inflammation

Volumn 16, Issue 3, 2008, Pages 83-87

  Lin, Yu Chi ^a,b   Yang, Chang Hao ^a   Lin, Chang Ping ^a   Yang, Chung May ^a   Chen, Muh Shy ^a   Chen, Mao Yuan ^a   Sheng, Wang Huei ^a   Hung, Chien Ching ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Shin Kong Wu Ho Su Memorial Hospital

Author keywords

Acquired immunodeficiency syndrome; Cytomegalovirus retinitis; Highly active antiretroviral therapy; Immune recovery uveitis; Macular edema

Indexed keywords

ANTIRETROVIRUS AGENT; GANCICLOVIR; TRIAMCINOLONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; RETINA MACULA EDEMA; RETINITIS; UVEITIS; VIRUS REACTIVATION; VISUAL ACUITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYTOMEGALOVIRUS RETINITIS; FEMALE; HUMANS; IMMUNE SYSTEM; INCIDENCE; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TAIWAN; UVEITIS;

EID: 45749087295     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940802056307     Document Type: Article

References (24)

1. Lederman MM, Conici E, Landay A, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trial Group Protocol 315. J Infect Dis. 1998;178:70-79.
2. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4 T-cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
3. Kuppermann BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis in human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575-582.
4. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 1996;114:821-827.
5. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
6. Holtzer CD, Jacobson MA, Hadley WK, et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital. AIDS 1998;12:1931-933.
7. Tural C, Romeu J, Sirera G, et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis. 1998;177:1080-1083.
8. Macdonald JC, Torriani FJ, Morse JS, et al. Lack od reactivation of cytomegalovirus retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevation in CD4 T cells in response to high active antiretroviral therapy. J Infect Dis. 1998;177:1182-1187.
9. Karavellas MP, Lowder CY, Macdonald C, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol. 1998;116:169-175.
10. Macdonald JC, Karavellas MP, Torriani FJ, et al. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology 2000;107:877-883.
11. Goldberg DE, Wang H, Azen SP, et al. Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy. Br J Ophthalmol. 2003;87:853-855.
12. Holland GN, Pepose JS, Petit TH, et al. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology 1983;90:859-873.
13. Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985;92:467-471.
14. Arevalo JF, Mendoza AJ, Ferretti Y. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela. Retina 2003;23:495-502.
15. Walsh JC, Jones CD, Barnes EA, et al. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including protease inhibitors. AIDS 1998;12:613-618.
16. Jabs DA, Vannatta ML, Kempen JH, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002;133:48-61.
17. Karavellas MP, Song MK, Macdonald JC, et al. Long term posterior and anterior segment complications of immune recovery uveitis associated with CMV retinitis. Am J Ophthalmol 2001;130:57-64.
18. Holland GN. Immune recovery Uveitis. Ocular Immunol Inflamm. 1999;7:215-221.
19. Song MK, Azen SP, Buley A, et al. Effect of anticytomegalovirus therapy on the incidence of immune recovery Uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol. 2003;136:696-702.
20. Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis following highly active antiretroviral therapy. Am J Ophthalmol. 2000;129:634-639.
21. Kupperman BD, Holland GN. Immune recovery uveitis. Am J Ophthalmol. 2000;130:103-106.
22. Karavella MP, Azen SP, Macdonald JC, et al. Immune recovery vitriris and uveitis in AIDS: clinical predictors, sequelae and treatment outcomes. Retina 2001;21:1-9.
23. Risk of immune recovery Uveitis in patients with AIDS and Cytomegalovirus retinitis. Ophthalmology 2006;113:684-694.
24. Zegan ME, Walton GC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination anti-retroviral therapy in patients with AIDS cytomegalovirus retinitis. Am J Ophthalmol. 1998;125:292-300.